CLINICAL TRIAL RESULTS

ECMO Bayesian analysis

Following publication of the EOLIA trial, many questions remain as to the role of early venovenous extracorporeal membrane oxygenation (ECMO) in very severe ARDS. 

In this icTV interview, Ewan Goligher (Toronto, Canada) describes the results of a post hoc Bayesian analysis of the EOLIA trial conducted to determine the probability that early ECMO reduces mortality in very severe ARDS. Results from this trial were presented during the Presidents’ Ground Breaking Research Release Session at LIVES 2018 in Paris and were just published in JAMA.

Read the article here.

Read the accompanying editorial here.